May 11 (Reuters) - ALX Oncology Holdings Inc ALXO.O :
* ALX ONCOLOGY REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS
AND
PROVIDES CLINICAL DEVELOPMENT AND OPERATIONAL HIGHLIGHTS
* ALX ONCOLOGY HOLDINGS INC - CASH, CASH EQUIVALENTS AND
INVESTMENTS AS OF MARCH 31, 2023 WERE $256.2 MILLION
* ALX ONCOLOGY:BELIEVES CASH, CASH EQUIVALENTS, INVESTMENTS
WITH
ABILITY TO DRAW DOWN $40MLN OF TERM LOAN SUFFICIENT TO FUND
PLANNED OPERATIONS THROUGH MID2025
Source text for Eikon: ID:nGNX9vyj92
Further company coverage: ALXO.O
((Reuters.Briefs@thomsonreuters.com;))